Synthesis and radiolabeling of chelator-RNA aptamer bioconjugates with copper-64 for targeted molecular imaging.
about
Nucleic Acid aptamers: new methods for selection, stabilization, and application in biomedical scienceApplications of aptamers in targeted imaging: state of the artBiomarkers in preclinical cancer imaging.GCPII imaging and cancer.Recent developments in protein and cell-targeted aptamer selection and applicationsScreening and characterization of a novel RNA aptamer that specifically binds to human prostatic acid phosphatase and human prostate cancer cells.Targeted inhibition of prostate cancer metastases with an RNA aptamer to prostate-specific membrane antigen.Aptamer technology for tracking cells' status & function.Improving external beam radiotherapy by combination with internal irradiationAdvantages of gadolinium based ultrasmall nanoparticles vs molecular gadolinium chelates for radiotherapy guided by MRI for glioma treatment."Click"-cyclized (68)Ga-labeled peptides for molecular imaging and therapy: synthesis and preliminary in vitro and in vivo evaluation in a melanoma model system.Molecular imaging with nucleic acid aptamers.Glutamate carboxypeptidase II in diagnosis and treatment of neurologic disorders and prostate cancerThe role of nuclear medicine in modern therapy of cancer.The ubiquitous DOTA and its derivatives: the impact of 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid on biomedical imaging.The application of aptamers in cancer research: an up-to-date review.PET imaging in prostate cancer: focus on prostate-specific membrane antigenThe prostate-specific membrane antigen: lessons and current clinical implications from 20 years of research.Vectors for the delivery of radiopharmaceuticals in cancer therapeutics.Distinguishing closely related amyloid precursors using an RNA aptamer.Molecular imaging of prostate cancer: translating molecular biology approaches into the clinical realm.Improved synthesis and biological evaluation of chelator-modified α-MSH analogs prepared by copper-free click chemistry.⁶⁴Cu-labeled inhibitors of prostate-specific membrane antigen for PET imaging of prostate cancer.Targeting PSMA with a Cu-64 Labeled Phosphoramidate Inhibitor for PET/CT Imaging of Variant PSMA-Expressing Xenografts in Mouse Models of Prostate Cancer.Metal-Based PSMA Radioligands.2-(3-{1-Carboxy-5-[(6-[18F]fluoro-pyridine-3-carbonyl)-amino]-pentyl}-ureido)-pentanedioic acid, [18F]DCFPyL, a PSMA-based PET imaging agent for prostate cancer.Derivatizations of Sgc8-c aptamer to prepare metallic radiopharmaceuticals as imaging diagnostic agents: Syntheses, isolations, and physicochemical characterizations.Aptamers and Glioblastoma: Their Potential Use for Imaging and Therapeutic Applications.
P2860
Q26995510-1C2EBBDD-E77E-47EB-9494-6DC06ED1B29BQ27011511-6348371E-38C4-4353-8269-D72FBDAD0670Q30416864-C57FE807-1989-4B05-9988-820338B82298Q33827632-8AFD9391-E64E-4A62-9EBB-EFDF535D2326Q33908491-41BE5050-D8A1-48CB-BCB6-7C4AE806C179Q35543331-E268D64D-A38E-4911-BD6E-E83897C4B7BFQ35600421-0F601E7A-0792-4D4C-BC3A-4BDFFD4D1B38Q35673895-190651DD-7EB7-486D-AAC5-E6DE45850391Q36235732-D4364D1F-BB94-484B-9DE7-C1C05105D3A2Q36245012-EB88BAB8-DC5A-4EFA-9EA5-1539C35C3E79Q37237829-9C32C8CC-E311-4B7F-980B-8ECF8944585DQ37916658-4E2BF551-5FF9-4878-BBA5-24DF9CB5AB19Q37972920-F6551453-D399-4807-BA35-C7F999A6D948Q37996849-AB2DD740-DA9C-4049-BF7B-9834D55FBD50Q38080002-DF80C3F1-187B-4ED2-A767-38CE66EFD770Q38087391-10F305EC-3E57-47EB-8186-B94C0C06EC80Q38099369-8EAC868B-0B69-46B6-986C-62C2BF393EA0Q38169828-4B8A07B2-43E4-457F-9AC6-37BC8B484D9AQ38261959-12C159F7-A5F8-45DF-8FAF-C9244B005599Q38305183-0BA5B06F-2406-458F-A19F-3677429D4372Q38360681-E14CD5D1-A6E4-4D2D-A9F5-9FD380847BE4Q38382330-5D13744E-BF8F-4CD7-BE15-1D7C490D97E4Q38705627-2854E513-197A-4AC2-9373-44753E8B6D01Q38820744-0856EEED-BA80-4FE4-9756-613955D695B5Q39198527-631097D2-E259-452D-9240-466F60B1FE89Q39449818-B1C901DF-0D91-4CD7-B74C-0EECF711679AQ47591838-27E7A932-4848-44CA-B8B9-62286804F57DQ47942947-D7A0EB44-80C7-46FC-9C57-3999800BD89B
P2860
Synthesis and radiolabeling of chelator-RNA aptamer bioconjugates with copper-64 for targeted molecular imaging.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Synthesis and radiolabeling of ...... or targeted molecular imaging.
@en
type
label
Synthesis and radiolabeling of ...... or targeted molecular imaging.
@en
prefLabel
Synthesis and radiolabeling of ...... or targeted molecular imaging.
@en
P2093
P2860
P1476
Synthesis and radiolabeling of ...... or targeted molecular imaging.
@en
P2093
Kyle C Kloepping
Ling Huang
Michael K Schultz
Nicholas J Baumhover
Paloma H Giangrande
William M Rockey
P2860
P304
P356
10.1016/J.BMC.2011.05.010
P407
P577
2011-05-14T00:00:00Z